These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 16897977)
1. [Combination chemotherapy of S-1 +CPT-11 (q 4-5 w) for metastatic gastric cancer]. Sugimoto N; Narahara H Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():79-82. PubMed ID: 16897977 [TBL] [Abstract][Full Text] [Related]
2. [CPT-11 combined chemotherapy for metastatic gastric cancer]. Narahara H; Sugimoto N; Iishi H; Tatsuta M Gan To Kagaku Ryoho; 2004 Nov; 31(12):1973-7. PubMed ID: 15570923 [TBL] [Abstract][Full Text] [Related]
3. [Clinical development of S-1 (TS-1) for advanced gastric cancer]. Wasaburo K; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Mihara S; Nakatani K; Nishimura K; Shimoda T; Azuma M; Katada C; Hanaoka N; Naruke A; Ryu T; Ishido K; Saigenji K Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():57-63. PubMed ID: 16897973 [TBL] [Abstract][Full Text] [Related]
4. [S-1 for gastric cancer-S-1 monotherapy and its progress]. Shitara K; Sakata Y; Kudou T; Munakata M Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():43-51. PubMed ID: 16897971 [TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer. Inokuchi M; Yamashita T; Yamada H; Kojima K; Ichikawa W; Nihei Z; Kawano T; Sugihara K Br J Cancer; 2006 Apr; 94(8):1130-5. PubMed ID: 16570038 [TBL] [Abstract][Full Text] [Related]
6. [Clinical development of chemotherapy for advanced gastric cancer]. Sato A; Matsukawa M Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):186-93. PubMed ID: 17283412 [No Abstract] [Full Text] [Related]
7. [The current evidence of S-1 and irinotecan hydrochloride combination chemotherapy with tri-weekly schedule]. Goto A Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():125-30. PubMed ID: 16897987 [TBL] [Abstract][Full Text] [Related]
8. [A randomized phase II clinical trial of tailored CPT-11 + TS-1 vs TS-1 in patients with advanced or recurrent gastric carcinoma as the first-line chemotherapy (JFMC31-0301)]. Takahashi Y; Takeuchi T; Sakamoto J; Mai M; Kitajima M; Kubota T; Toge T; Saji S Gan To Kagaku Ryoho; 2004 Nov; 31(12):1969-72. PubMed ID: 15570922 [TBL] [Abstract][Full Text] [Related]
9. Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial. Nishikawa K; Fujitani K; Inagaki H; Akamaru Y; Tokunaga S; Takagi M; Tamura S; Sugimoto N; Shigematsu T; Yoshikawa T; Ishiguro T; Nakamura M; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J; Tsujinaka T Eur J Cancer; 2015 May; 51(7):808-16. PubMed ID: 25797356 [TBL] [Abstract][Full Text] [Related]
10. Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002). Takiuchi H; Narahara H; Tsujinaka T; Gotoh M; Kawabe S; Katsu K; Iishi H; Tatsuta M; Fujitani K; Furukawa H; Taguchi T; Jpn J Clin Oncol; 2005 Sep; 35(9):520-5. PubMed ID: 16141295 [TBL] [Abstract][Full Text] [Related]
11. Rapid development of S-1 in the west for therapy of advanced gastric carcinoma. Ajani JA Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():117-20. PubMed ID: 16897985 [TBL] [Abstract][Full Text] [Related]
12. [A case of advanced gastric cancer with multiple liver metastasis responding to S-1 and irinotecan combination therapy]. Kuga T; Oka K; Yamashita A; Fujii Y; Hanashima M; Hamano K Gan To Kagaku Ryoho; 2011 Aug; 38(8):1333-6. PubMed ID: 21829075 [No Abstract] [Full Text] [Related]
13. [Chemotherapy for gastric cancer]. Baba H; Kakeji Y; Oki E; Tokunaga E; Ushiro S; Watanabe M; Maehara Y Gan To Kagaku Ryoho; 2003 Nov; 30(12):1881-8. PubMed ID: 14650954 [TBL] [Abstract][Full Text] [Related]
14. [Controversial issues in chemotherapy for inoperable gastric cancer]. Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Kitamura T; Azuma M; Saigenji K Gan To Kagaku Ryoho; 2003 Sep; 30(9):1249-55. PubMed ID: 14518402 [TBL] [Abstract][Full Text] [Related]
15. [The choice of treatment in advanced gastric cancer]. Pozzo C; Mansueto G Tumori; 2007; 93(6):suppl 11-21. PubMed ID: 18338512 [No Abstract] [Full Text] [Related]
16. [Current evidence of irinotecan combination chemotherapy with TS-1 in patients with advanced colorectal cancer]. Goto A Gan To Kagaku Ryoho; 2006 Jul; 33(7):896-900. PubMed ID: 16835475 [TBL] [Abstract][Full Text] [Related]
17. [Second-line chemotherapy in gastric cancer following S-1 with CPT-11 chemotherapy performed as clinical trial]. Inokuchi M; Yamashita T; Yamada H; Kojima K; Sekita Y; Kawano T; Sugihara K Gan To Kagaku Ryoho; 2007 Jun; 34(6):875-9. PubMed ID: 17565249 [TBL] [Abstract][Full Text] [Related]
18. [A recent trial of chemo-radiation with S-1 against gastric cancer]. Saikawa Y; Kiyota T; Nakamura R; Wada N; Yoshida M; Kubota T; Kumai K; Shigematsu N; Kubo A; Kitajima M Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():99-105. PubMed ID: 16897982 [TBL] [Abstract][Full Text] [Related]
19. [Irinotecan plus oral S-1 in patients with advanced gastric cancer-biweekly IRIS regimen]. Komatsu Y; Yuki S; Miyagishima T; Asaka M Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():75-8. PubMed ID: 16897976 [TBL] [Abstract][Full Text] [Related]
20. [A resected case of effective treatment with S-1+CPT-11 combination chemotherapy for advanced gastric cancer]. Kojima Y; Kii T; Takiuchi H; Kuwakado S; Kawabe S; Gotoh M; Yoshida M; Higuchi K; Egashira Y; Tanigawa N Gan To Kagaku Ryoho; 2010 Jul; 37(7):1381-4. PubMed ID: 20647732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]